Delivery Order SPE2DB22D2211-SPE2DB25FSGEB
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 12, 2025, for the supply of Betaseron 0.3 mg kits valued at $16,778.88. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with DLA, which procures medical supplies...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,266.27 by the Defense Logistics Agency on August 12, 2025, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, which carries an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits with a ceiling value of $82,716.10 under a firm fixed-price contract type. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,859.47 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- The Defense Logistics Agency has awarded a delivery order valued at $59,367.66 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, issued on September 24, 2025, with completion expected by September 25, 2025, represents a non-competitive set-aside arrangement and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for $61,750.04 to supply Betaseron 0.3 mg kits. This is a firm fixed-price delivery order with an ultimate completion date of July 8, 2025, and performance will be executed at the contractor's Conshohocken, Pennsylvania facility. The award was made without a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $49,832.19 to Amerisourcebergen Drug Corporation to provide 4562003781 Betaseron 0.3 mg kits. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the multiple sclerosis drug to locations within its parent company Amerisourcebergen Corporation's Conshohocken, Pennsylvania facility. The delivery order was issued on August 30, 2023 under an existing DLA contract vehicle and is to be completed by...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical valued at $14,734.37. The contract is for the delivery of 0.3 mg BETASERON medication kits, which are specialty pharmaceutical products used to treat certain medical conditions. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC)...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSGEBDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,674.09 by the Defense Logistics Agency for the supply of Betaseron 0.3 mg kits, with a completion date of September 30, 2025. This firm fixed-price delivery order, awarded on September 29, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies to support defense healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Betaseron is a disease-modifying therapy used in the treatment of multiple sclerosis, reflecting the company's role in providing specialized medications across multiple therapeutic domains to federal medical supply chains. AmerisourceBergen's extensive federal procurement portfolio and demonstrated capability to compete successfully for pharmaceutical supply contracts position the company as a significant vendor supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 9/29/25 |